肠道菌群和心血管疾病的免疫调节
DOI:
作者:
作者单位:

(1.哈尔滨医科大学附属第二医院心内科,黑龙江省哈尔滨市 150001;2.心肌缺血教育部重点实验室, 黑龙江省哈尔滨市 150001;3.华东理工大学药学院,上海市 200237)

作者简介:

倪文君,硕士研究生,研究方向为动脉粥样硬化的分子机制,E-mail:niwenjun0204@163.com。通信作者田进伟,博士,主任医师,博士研究生导师,研究方向为动脉粥样硬化的分子机制,E-mail:tianjinweidr2009@163.com。通信作者张健,博士,研究员,博士研究生导师,研究方向为心血管疾病及相关代谢综合征的疾病机制研究和新靶标的发现,E-mail:zhangjian7@ecust.edu.cn。

通讯作者:

基金项目:

国家自然科学基金联合基金项目(U21A20391);黑龙江省应用技术研究与开发计划(GA20C007);京津冀基础研究合作专项(20JCZXJC00150)


Gut microbiota and immune regulation of cardiovascular diseases
Author:
Affiliation:

1.Department of Cardiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China;2.The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, Heilongjiang 150001, China;3.School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    心血管疾病是人类健康的第一杀手,发病率和死亡率逐年增加。数万亿微生物寄居于人类肠道,在心血管疾病及其相关的代谢、免疫反应中发挥着至关重要的作用。先天性和适应性免疫机制都参与了心血管疾病的发生发展,菌群组分和代谢产物可调节巨噬细胞、淋巴细胞等免疫细胞的分化及功能,并通过循环系统影响机体免疫稳态。本文将通过肠道菌群及其代谢产物与免疫系统的相互作用,讨论肠道菌群与心血管疾病发展之间潜在的免疫机制,为预防和治疗心血管疾病提供新思路。

    Abstract:

    Cardiovascular disease (CVD) has become the number one killer worldwide, and the morbidity and mortality significantly increased. Trillions of microorganisms inhabit the human gut and play crucial roles in metabolism, immunity and responses to diseases. Previous studies have demonstrated a correlation between cardiovascular diseases and gut microbiota. Both innate and adaptive immune mechanisms can affect the occurrence and development of cardiovascular diseases. The specific components and metabolites of gut microorganisms can regulate the differentiation and function of immune cells such as macrophages and lymphocytes, as well as influence the immune homeostasis through circulatory system. This review discusses the potential immune mechanisms between the gut microbiota and the development of cardiovascular diseases through the interaction of the gut microbiota and its metabolites with the immune system, which provides new insights into the prevention and treatment of cardiovascular diseases.

    参考文献
    相似文献
    引证文献
引用本文

倪文君,王雪羽,钟珊,赵鹏,张健,田进伟.肠道菌群和心血管疾病的免疫调节[J].中国动脉硬化杂志,2023,31(7):625~631.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2022-11-03
  • 最后修改日期:2023-03-11
  • 录用日期:
  • 在线发布日期: 2023-09-01